Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment and Outcomes of Patients Identified With Non-Histaminergic Angioedema With Normal C1 Inhibitor in Canada

NCT05578417 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05578417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05578417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment and Outcomes of Patients Identified With Non-Histaminergic Angioedema With Normal C1 Inhibitor in Canada
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
June 15, 2023
Completion date
June 30, 2024
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

angioedema, hereditary angioedema (hae)